ORGANIZATION INFO.
Advanced Genomics APAC is a branch established by a UK company (Advance Genomics) to expand in the Asia-Pacific region and founded in 2023. Advanced Genomics APAC is also a subsidiary of Nonacus (A leading provider of genetic testing products based in Birmingham, UK). The company works with scientists and clinicians to provide a complete workflow for primary tumor and liquid biopsy analysis with the ultimate goal of enabling enhanced care through earlier diagnosis, treatment stratification and monitoring. With a wealth of experience in biotechnology, the Nonacus team continually drives laboratory technology advancements, underpinning their dedication to pioneering research and development.
Nonacus, is a British firm established in 2015 and headquartered at the Birmingham Biological Center in the UK, and is dedicated to enhancing the medical diagnosis process. The company's expert team specializes in tumor biology, cancer genomics and uses state-of-the-art bioinformatics analysis. They also utilize modern genomic testing techniques to aid in the early detection in order to aid doctors and other medical professionals in detection and treatment of cancer in early stages. Through next-generation sequencing technology in testing and integrated service platforms, each cancer patient’s genomic data is incorporated into effective and personalized treatment solutions
Our goal is to democratize non-invasive genetic testing globally with a focus on oncology so that we can enable decentralized, cost-effective and cutting-edge cancer detection and longitudinal patient monitoring. Detecting cancer earlier and informing patient outcomes through the deployment of a truly innovative liquid biopsy testing platform. Detecting cancer earlier and informing patient outcomes through the deployment of a truly innovative liquid biopsy testing platform.
